Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
John Behman
Clinical Affiliate in the Department of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
john.behman@duke.edu
Inpatient DCT 10B/11A, 2301 Erwin Road, Durham, NC 27710
Scholarly Works
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Duke Appointments & Affiliations
global-scholarship {hide_children: true, active: false, enabled: false}
Global Scholarship
keywords {hide_children: true, active: false, enabled: false}
Keywords
research {hide_children: true, active: false, enabled: false}
Research
scholarly-works {hide_children: false, active: true, enabled: true}
Scholarly Works
Featured Works
Journal articles
teaching-mentoring {hide_children: true, active: false, enabled: false}
Teaching & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Scholarly Works
Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma
Journal article
Haematologica
·
July 2, 2026
Not available. ...
Full text
Cite
CD5- B-cell lymphocytic leukemia -a diagnostic exclusion of splenic B-cell leukemia with prominent nuclei challenging current international consensus.
Journal article
Leuk Lymphoma
·
August 2025
Full text
Link to item
Cite
